NasdaqGS - Delayed Quote • USD
Nkarta, Inc. (NKTX)
At close: 4:00 PM EDT
After hours: 5:27 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -0.44 | -0.44 | -1.89 | -1.93 |
| Low Estimate | -0.65 | -0.66 | -2.44 | -2.52 |
| High Estimate | -0.36 | -0.35 | -1.66 | -1.51 |
| Year Ago EPS | -0.68 | -0.52 | -2.4 | -1.89 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 6 | 6 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.68 | -0.67 | -0.59 | -0.56 |
| EPS Actual | -0.68 | -0.52 | -0.57 | -0.58 |
| Difference | 0 | 0.15 | 0.02 | -0.02 |
| Surprise % | 0.00% | 22.40% | 3.40% | -3.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.44 | -0.44 | -1.89 | -1.93 |
| 7 Days Ago | -0.44 | -0.44 | -1.89 | -1.93 |
| 30 Days Ago | -0.52 | -0.52 | -2.1 | -2.07 |
| 60 Days Ago | -0.52 | -0.52 | -2.1 | -2.07 |
| 90 Days Ago | -0.61 | -0.55 | -2.49 | -2.37 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 3 | 3 | 4 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NKTX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 35.30% | -- | -- | 7.90% |
| Next Qtr. | 15.40% | -- | -- | 10.20% |
| Current Year | 21.20% | -- | -- | 4.80% |
| Next Year | -2.10% | -- | -- | 12.50% |
| Next 5 Years (per annum) | -- | -- | -- | 11.27% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/13/2024 |
| Maintains | Needham: Buy to Buy | 5/13/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 5/10/2024 |
| Reiterates | Needham: Buy to Buy | 4/10/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 3/26/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/25/2024 |
Related Tickers
SANA Sana Biotechnology, Inc.
7.80
-2.74%
PASG Passage Bio, Inc.
1.1900
+5.31%
CABA Cabaletta Bio, Inc.
10.67
-2.29%
BDTX Black Diamond Therapeutics, Inc.
4.7000
-3.89%
PLRX Pliant Therapeutics, Inc.
12.88
+1.18%
ALXO ALX Oncology Holdings Inc.
12.56
-4.63%
IDYA IDEAYA Biosciences, Inc.
37.53
-0.48%
CCCC C4 Therapeutics, Inc.
5.36
-2.19%
ADCT ADC Therapeutics SA
3.5700
-2.99%
KYMR Kymera Therapeutics, Inc.
33.53
-1.53%